ResMed has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results